NCT07743593 Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers Status NOT_YET_RECRUITING Phase PHASE3
NCT07708727 Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment Status RECRUITING Phase PHASE2/PHASE3
NCT07683000 Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens Status RECRUITING Phase PHASE3
NCT07645287 A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 Status RECRUITING Phase PHASE2
NCT07616739 Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women Status NOT_YET_RECRUITING Phase PHASE4
NCT07596888 IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study Status RECRUITING Phase PHASE1
NCT07579546 PERsistance of Long-Acting inJEctable CAB+RPV in a Cohort of Virologically-suppressed PLWH: a Real-life Study Status NOT_YET_RECRUITING Phase N/A
NCT07357584 Efficacy and Safety of Doravirine in the Rapid Initiation Status NOT_YET_RECRUITING Phase PHASE4
NCT07293559 Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States Status RECRUITING Phase N/A
NCT07081763 Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption Status NOT_YET_RECRUITING Phase PHASE2
NCT07080138 Research on the Psychological Status of Patients With HIV-1 Infection Status NOT_YET_RECRUITING Phase N/A
NCT07055451 Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06987318 A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection Status NOT_YET_RECRUITING Phase PHASE1
NCT06919016 A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06905275 A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV Status SUSPENDED Phase PHASE1
NCT06774872 Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully Status RECRUITING Phase PHASE2